Armand Butera

Though no research on the effects of positive emotion intervention on children with asthma exist, investigators note that the methods have shown positive results in other health contexts.

Recent data from phase 3 clinical trials of the antibody shows significant skin clearance and itch in people with atopic dermatitis.

With immunosuppressed populations at an increased risk of death and comorbidities due to COVID-19, members of the Advisory Committee of Immunization Practices moved to approve additional doses for young at-risk patients.

Investigators link early atopic manifestations and other complications to tree nut allergy, which account for most of all food related deaths by anaphylaxis.

Staff from schools across the United Kingdom express desire for enhanced staff preparedness and internal allergy policy review after being surveyed by investigators.

Investigators from Spain contribute to the dialogue surrounding postvaccine antibodies with a study that looks exclusively at the COVID-19 vaccine’s affect on breastfeeding mothers.

An ongoing study of the IL-17A and IL-17F inhibitor showed patients with moderate to severe plaque psoriasis achieved long-term skin clearance results.

A new follow-up study highlights the efficacy and safety of the daily oral immunotherapy in. younger patient populations.

A new study suggests the Asthma Predictive Index can be used as a simple, noninvasive tool for determining asthma in preschoolers.

A new multi-year study shows that the immunotherapy increases tolerance of peanut products in patients with allergies.

Researchers report antibody responses in kidney transplant recipients and the impact of specific regiments utilized by select patients.

Research showed that the second dose of the COVID-19 vaccine was well tolerated by patients who experienced allergic reactions from their first dose.

The biologic can now be used as an add-on maintenance treatment for patients who have struggled with former treatment and surgeries.

Researchers note the severity of the disease significantly impacts patients’ sleep habits, medication intake, and general mental and physical health.

Researchers in North Carolina recorded improvements in pediatric healthcare utilization partly attributed to a lack of exposure to allergens and other exacerbations.

The priorities established by a panel of experts are designed to improve efficacy and equity in kidney research and care.

Dr. Martin explains the connection between inclusive cardiology technology and patient care and confidence.

Advancements in technology and the availability of resources for patients and doctors alike could mean a bright future for cardiology research.

Dr. Taub speaks on the technology-based advancements in cardiovascular care and socioeconomic status can affect a patient’s diet and access to care.

Dr. Pam Taub speaks on the misconceptions of cardiac rehabilitation and other lifestyle approaches recommended for patients with cardiovascular diseases.

Dr. Mazzocchi discusses the limits and benefits of immunotherapies, as well as the importance of genetic testing in determining cancer diagnosis and treatment in patients.

While investigators did not meet their primary endpoint in the study, results in former smokers within the trial were promising and prompted further research on the subgroup.

Andrea Mazzocchi, PhD, explains how tissue and blood samples can be used to improve detection, progression, and treatment for cancer in patients.

Orphaned children experience greater risk of abuse and health complications, prompting a call to action for greater research and management of COVID-19 in ailing countries.

A leading author of a recent Oxford study speaks of azithromycin, its limitations in treating patients with COVID-19, and the importance of properly utilizing the antibiotic.

Using a participant group culled from several countries, investigators believe they have a better understanding on what contributes to uncontrolled allergic rhinitis and what it means for future patient care.

Researchers aimed to establish new treatments for patients with COVID-19, but found no evidence of antiviral benefits or decreases in hospitalization and ventilation rates.

Despite its accessibility and affordability, azithromycin does not positively affect patients with COVID-19, according to a new UK study.